Cargando…

Landscape of exitrons in gastric cancer

BACKGROUND: Exitron is a new type of non-canonical alternative splicing. Accumulating evidence implies exitron may have pathological function and contribute to another source of anti-tumor immunogenicity in various cancers. Its role in gastric cancer remains poorly understood. Large-scale, multi-omi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yihao, Ye, Gengtai, Yang, Qingbin, Zheng, Boyang, Zhang, Guofan, Hu, Yanfeng, Yu, Jiang, Li, Guoxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494173/
https://www.ncbi.nlm.nih.gov/pubmed/36137412
http://dx.doi.org/10.1016/j.ebiom.2022.104272
_version_ 1784793756383313920
author Zhang, Yihao
Ye, Gengtai
Yang, Qingbin
Zheng, Boyang
Zhang, Guofan
Hu, Yanfeng
Yu, Jiang
Li, Guoxin
author_facet Zhang, Yihao
Ye, Gengtai
Yang, Qingbin
Zheng, Boyang
Zhang, Guofan
Hu, Yanfeng
Yu, Jiang
Li, Guoxin
author_sort Zhang, Yihao
collection PubMed
description BACKGROUND: Exitron is a new type of non-canonical alternative splicing. Accumulating evidence implies exitron may have pathological function and contribute to another source of anti-tumor immunogenicity in various cancers. Its role in gastric cancer remains poorly understood. Large-scale, multi-omics analysis could comprehensively characterize the landscape of exitrons in gastric cancer, reveal undiscovered mechanism and hopefully identify molecular biomarkers for predicting immunotherapy response. METHODS: We collected datasets from five studies for analysis. RNA sequencing was used for exitron identification. Somatic mutations were detected by whole exome sequencing. Neopeptides were confirmed by proteome mass spectrometry. FINDINGS: 42174 gastric cancer-specific exitrons (GCSEs) were identified in 632 patients. GCSEs were clinically relevant to gender, age, Lauren type, tumor stage and prognosis. Tissue specificity test and pathogenic exitron prediction revealed their unique functional impact. GCSEs were mutually exclusive with mutations and demonstrated both unique and complementary function against TP53 mutation in gastric cancer. We further established splicing regulatory network to reveal upstream regulation of exitron splicing. We also evaluated the immunogenicity and diagnostic potential of GCSEs. Evidence of GCSEs-derived neopeptide expression was validated by whole proteome mass spectrometry. PD-1 and Siglecs were significantly increased in high neoantigen load patients. But exitron-related biomarkers failed to predict immunotherapy response, possibly due to small sample size and insufficient sequencing depth. INTERPRETATION: The present study provided a comprehensive multidimensional landscape of gastric cancer exitrons and underscores insights into underexplored mechanism in gastric cancer pathology. FUNDING: The Guangdong Provincial Key Laboratory of Precision Medicine for Gastroinstestinal Cancer (2020B121201004), the Guangdong Provincial Major Talents Project (No. 2019JC05Y361) and National Natural Science Foundation of China (grant number:82172960 and 81872013).
format Online
Article
Text
id pubmed-9494173
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94941732022-09-23 Landscape of exitrons in gastric cancer Zhang, Yihao Ye, Gengtai Yang, Qingbin Zheng, Boyang Zhang, Guofan Hu, Yanfeng Yu, Jiang Li, Guoxin eBioMedicine Articles BACKGROUND: Exitron is a new type of non-canonical alternative splicing. Accumulating evidence implies exitron may have pathological function and contribute to another source of anti-tumor immunogenicity in various cancers. Its role in gastric cancer remains poorly understood. Large-scale, multi-omics analysis could comprehensively characterize the landscape of exitrons in gastric cancer, reveal undiscovered mechanism and hopefully identify molecular biomarkers for predicting immunotherapy response. METHODS: We collected datasets from five studies for analysis. RNA sequencing was used for exitron identification. Somatic mutations were detected by whole exome sequencing. Neopeptides were confirmed by proteome mass spectrometry. FINDINGS: 42174 gastric cancer-specific exitrons (GCSEs) were identified in 632 patients. GCSEs were clinically relevant to gender, age, Lauren type, tumor stage and prognosis. Tissue specificity test and pathogenic exitron prediction revealed their unique functional impact. GCSEs were mutually exclusive with mutations and demonstrated both unique and complementary function against TP53 mutation in gastric cancer. We further established splicing regulatory network to reveal upstream regulation of exitron splicing. We also evaluated the immunogenicity and diagnostic potential of GCSEs. Evidence of GCSEs-derived neopeptide expression was validated by whole proteome mass spectrometry. PD-1 and Siglecs were significantly increased in high neoantigen load patients. But exitron-related biomarkers failed to predict immunotherapy response, possibly due to small sample size and insufficient sequencing depth. INTERPRETATION: The present study provided a comprehensive multidimensional landscape of gastric cancer exitrons and underscores insights into underexplored mechanism in gastric cancer pathology. FUNDING: The Guangdong Provincial Key Laboratory of Precision Medicine for Gastroinstestinal Cancer (2020B121201004), the Guangdong Provincial Major Talents Project (No. 2019JC05Y361) and National Natural Science Foundation of China (grant number:82172960 and 81872013). Elsevier 2022-09-19 /pmc/articles/PMC9494173/ /pubmed/36137412 http://dx.doi.org/10.1016/j.ebiom.2022.104272 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles
Zhang, Yihao
Ye, Gengtai
Yang, Qingbin
Zheng, Boyang
Zhang, Guofan
Hu, Yanfeng
Yu, Jiang
Li, Guoxin
Landscape of exitrons in gastric cancer
title Landscape of exitrons in gastric cancer
title_full Landscape of exitrons in gastric cancer
title_fullStr Landscape of exitrons in gastric cancer
title_full_unstemmed Landscape of exitrons in gastric cancer
title_short Landscape of exitrons in gastric cancer
title_sort landscape of exitrons in gastric cancer
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494173/
https://www.ncbi.nlm.nih.gov/pubmed/36137412
http://dx.doi.org/10.1016/j.ebiom.2022.104272
work_keys_str_mv AT zhangyihao landscapeofexitronsingastriccancer
AT yegengtai landscapeofexitronsingastriccancer
AT yangqingbin landscapeofexitronsingastriccancer
AT zhengboyang landscapeofexitronsingastriccancer
AT zhangguofan landscapeofexitronsingastriccancer
AT huyanfeng landscapeofexitronsingastriccancer
AT yujiang landscapeofexitronsingastriccancer
AT liguoxin landscapeofexitronsingastriccancer